Skip to main content
Smart Investors Daily
VE

NASDAQ · VERO

Venus Concept Inc.

Healthcare · Medical - Devices

$0.31

Up+$0.01 (+2.64%)

Updated Oct 12, 2026, 7:46 AM

SID Score

4.3/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
3.47M
P/E ratio
-0.06
Dividend yield
0.00%
52-week range
— – —
Volume
43
Avg. volume
633.97K

Price performance · VERO

VERO price history

1M range · 0 trading sessions · Daily adjusted prices

VERO does not have enough price history for the selected period.

Data unavailable

Market data is busy. Please try again shortly.

Latest VERO news

The latest Smart Investors Daily articles mentioning VERO.

VERO research

Overview

Company profile and research snapshot.

Company profile

Venus Concept Inc is a medical technology company. It develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services. The company's products include NeoGraft, Venus Viva, Venus Legacy, Venus Versa, Venus Velocity, Venus Bliss, ARTAS systems, and others. The company provides medical devices and treatments for hair, body, and skin-related problems. It generates a majority of its revenue from the United States.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Hold
Average target
$10.81
Implied upside
—
Analysts
7
VERO recent ratings
DateFirmRatingTarget
Oct 6, 2023BTIGNeutral—
Mar 28, 2023Ladenburg ThalmannBuy—
Mar 28, 2023Maxim GroupHold—
Jun 24, 2022BTIGBuy—
Dec 9, 2020StifelHold—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Nov 13, 2025

Venus Concept: Q3 Earnings Snapshot

TORONTO (AP) — Venus Concept Inc. VERO) on Thursday reported a loss of $22.6 million in its third quarter. The Toronto-based company said it had a loss of $12.14 per share.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.